Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Ascletis Presented Positive Phase I Clinical Data for Broad-Spectrum Antiviral Double Prodrug ASC10 at CROI 2023 2023-02-21 08:10
iGene Laboratory Announces Launch of Whole Exome Sequencing Service 2023-02-21 08:00
Bridge Biotherapeutics Presents Phase 2a Clinical Trial Results For BBT-401, a Drug Candidate to Treat Ulcerative Colitis 2023-02-21 07:00
Celltrion and LISCure Biosciences announce strategic collaboration to develop novel microbiome treatment for Parkinson's disease 2023-02-20 22:00
Duoning Enters Partnership with BioAces to Expand Cell Analysis Portfolio 2023-02-20 20:00
Angel Yeast Announces Plans to Beef up Supply and Innovation Capabilities In Response to Increasing Global Yeast Demand 2023-02-20 20:00
GC Biopharma Receives WHO Pre-Qualification for BARYCELA 2023-02-20 09:38
Detailed Results from Telix's ZIRCON Phase III Kidney Cancer Imaging Study Presented at ASCO GU 2023-02-20 07:10
Terumo Blood and Cell Technologies' IMUGARD Platelet Pooling Set Cleared by FDA 2023-02-17 03:48
GLOBAL SARCOMA THERAPY NOW APPROVED FOR NEW ZEALAND PATIENTS 2023-02-17 03:00
Immuno Cure kick off Phase I Clinical Trial in Shenzhen 2023-02-16 20:36
Alibaba Entrepreneurs Fund Launches JUMPSTARTER 2023 Global Pitch Competition 2023-02-16 18:23
Oral Presentation at APASL Annual Meeting 2023 Demonstrates ASC22, a Subcutaneous PD-L1 Antibody, Can Achieve Functional Cure of Chronic Hepatitis B 2023-02-16 17:10
Pharming provides update on EMA regulatory review of leniolisib for APDS in Europe 2023-02-16 14:00
GNOMIX: An Australian Case Study to Democratise Clinical Applications of Genomics with MGI's DNBSEQ™ Platforms 2023-02-16 12:00
Boan Biotech's Investigational Long-acting Anti-IL-4Rα Antibody BA2101 Administered for First Patient in Phase I Clinical Trial 2023-02-16 08:15
WuXi AppTec Named "Industry Mover" in S&P Global Sustainability Yearbook 2023 2023-02-16 08:00
Innovent Announces First Patient Dosed in a Phase 3 Clinical Trial (CLEAR) of Picankibart (Anti-IL23p19 Monoclonal Antibody) in Patients with Moderate-to-Severe Plaque Psoriasis 2023-02-16 08:00
Inventia Life Science collaborates with MSD to develop 3D advanced cell models for neurodegenerative disease drug discovery 2023-02-16 06:00
Tetracore Announces USDA Purchase of ASF and FMD Diagnostic Test Kits 2023-02-16 04:35
1 125 126 127 128 129 453